General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amarin(SIGNIFICANT), Akcea(SIGNIFICANT) SPEAKER'S BUREAU: Amarin(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Eli Lilly and Company(SIGNIFICANT), Ionis (Akcea)(SIGNIFICANT), Mylan Inc.(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Dexcom(SIGNIFICANT), Allergan(MODEST)

View Full Disclosure